Scientists have linked roughly five percent of adult cancers to mutations in genes called FOCAD and TTC37. Another gene known ...

Neoantigen-targeting personalized cancer vaccines (PCVs) are highly immunogenic in high-risk clear cell renal cell carcinoma ...

Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell ...

A major breakthrough in cancer genetics has been achieved, paving the way for more effective prevention, early detection, and ...

In the latest study, researchers found the main genetic mutations in renal cell cancer, possibly by using artificial intelligence (AI). The scientists injected mRNA vaccine made against proteins ...

Breast cancer is one of the most common cancers worldwide, affecting both women and men, though it is far more prevalent in ...

Battling a rare form of cancer, Massi Agosti of Penn Valley found unwavering support from the Eagles and the player he loved most: wide receiver A.J. Brown.

A new case report details a novel genetic mutation linked to drug resistance in a non-small cell lung cancer patient ...

Treatment with Tafinlar in combination with Mekinist showed what researchers described as “considerable efficacy” among ...

Three trials presented at ASCO GI 2025 will change practice and improve the treatment of colorectal cancer, according to experts.

Bristol Myers Squibb's FDA nod for Breyanzi (liso-cel) in relapsed/refractory CLL/SLL boosts its CAR T-cell portfolio, ...

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast amounts of complex biological data into two-dimensional circular images.